Vaccination with staphylococcal protein A protects mice against systemic complications of skin infection recurrences.
SSTIs
Staphylococcus
bacteremia
immunomodulators
mouse model
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2024
2024
Historique:
received:
14
12
2023
accepted:
16
02
2024
medline:
26
3
2024
pubmed:
26
3
2024
entrez:
26
3
2024
Statut:
epublish
Résumé
Skin and soft tissue infections (SSTIs) are the most common diseases caused by
Identifiants
pubmed: 38529283
doi: 10.3389/fimmu.2024.1355764
pmc: PMC10961379
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1355764Informations de copyright
Copyright © 2024 Mandelli, Magri, Tortoli, Torricelli, Laera, Bagnoli, Finco, Bensi, Brazzoli and Chiarot.
Déclaration de conflit d'intérêts
AM was a PhD student of Università degli Studi di Siena Italy at the time of the study and supervised by GSK. GM was a student of Università di Bologna Italy at the time of the study and participated in an internship at GSK. AM is now an employee of GiGroup SpA, a contract employment organization contracted by GSK. GM is now an employee of GSK. DL and GB were employee of GSK at the time of the study. All the other authors are employee of GSK. FB, MB, GB, EC report ownership of GSK shares. FB is listed as inventor on patents concerning S. aureus vaccine development. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.